Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial
Flippot, R., Dalban, C., Laguerre, B., Borchiellini, D., Gravis, G., Negrier, S., Chevreau, C.M., Joly, F., Geoffrois, L., Ladoire, S., Mahammedi, H., Tantot, F., Escudier, B., Albiges, L.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Oncogenic osteomalacia: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case
Dupond, J.L., Mahammedi, H., Prié, D., Collin, F., Gil, H., Blagosklonov, O., Ricbourg, B., Meaux-Ruault, N., Kantelip, B.
Published in Bone (New York, N.Y.) (01.03.2005)
Published in Bone (New York, N.Y.) (01.03.2005)
Get full text
Journal Article
2594 Safety and efficacy of Temsirolimus (Torisel®) as second line treatment for patients with recurrent bladder cancer
Houede, N, Roubaud, G, Mahammedi, H, Vedrine, L, Joly, F, Mourey, L, Pfister, C, Culine, S, Goberna, A, Lortal, B, Pulido, M, Pourquier, P, Bellera, C
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Adherence with Oral Oncologic Treatment in Cancer Patients: Interest of an Adherence Score of All Dosing Errors
Thivat, E., Van Praagh, I., Belliere, A., Mouret-Reynier, M.A., Kwiatkowski, F., Durando, X., Mahammedi, H., Dillies, A.F., Chollet, P., Chevrier, R.
Published in Oncology (01.01.2013)
Published in Oncology (01.01.2013)
Get full text
Journal Article
Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial
Pfister, Christian, Harter, Valentin, Allory, Yves, Radvanyi, François, Culine, Stéphane, Grawis, G., Pignot, G., Flechon, A., Fendler, J.P., Chevreau, C., Soulie, M., Mahammedi, H., Guy, L., Laguerre, B., Verhoest, G., Guillot, A., Mottet, N., Joly, F., Doerfler, A., Abadie-Lacourtoisie, S., Azzouzi, A.R., Mongiat, P., Geoffrois, L., Eschwege, P., Di Fiore, F., Roubaud, G., Hoepffner, J.L., Barthelemy, P., Lang, H., Voog, E., Mandron, E., Tourani, J.M., Serrrate, C., Colau, A., Saldana, C., de La Taille, A., Nguyen, T., Kleinclauss, F., Loriot, Y., Irani, J., Eymard, J.C., Larre, S., Huillard, O., Zerbib, M., Rolland, F., Rigaud, J., Houede, N., Droupy, S., Malouf, G., Roupret, M., El Demery, M., Legon, C., Vieillot, S., Letang, N., Lharidon, T., Gaschignard, N., Hilgers, W., Davin, J.L.
Published in Contemporary clinical trials communications (01.03.2020)
Published in Contemporary clinical trials communications (01.03.2020)
Get full text
Journal Article
Medical treatment of renal cell carcinoma
Guy, L, Bay, J-O, Bastide, C, Mahammedi, H, Bruyere, F, Karsenty, G
Published in Progrès en urologie (Paris) (01.11.2013)
Published in Progrès en urologie (Paris) (01.11.2013)
Get more information
Journal Article
7045 POSTER Docetaxel and Curcuminoids Combination in Patients With Hormone Resistant Prostate Cancer – a Phase II Study
Mahammedi, H, Planchat, E, Durando, X, Barthomeuf, C, Bayet-Robert, M, Van-Praagh, I, Francannet, P, Guy, L, Chollet, P, Eymard, J.C
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Kwon, Eugene D, Prof, Drake, Charles G, MD, Scher, Howard I, Prof, Fizazi, Karim, Prof, Bossi, Alberto, MD, van den Eertwegh, Alfons J M, MD, Krainer, Michael, MD, Houede, Nadine, MD, Santos, Ricardo, MD, Mahammedi, Hakim, MD, Ng, Siobhan, MD, Maio, Michele, MD, Franke, Fabio A, MD, Sundar, Santhanam, MBBS, Agarwal, Neeraj, MD, Bergman, Andries M, MD, Ciuleanu, Tudor E, Prof, Korbenfeld, Ernesto, MD, Sengeløv, Lisa, MD, Hansen, Steinbjorn, MD, Logothetis, Christopher, Prof, Beer, Tomasz M, Prof, McHenry, M Brent, PhD, Gagnier, Paul, MD, Liu, David, MD, Gerritsen, Winald R, Prof
Published in The lancet oncology (01.06.2014)
Published in The lancet oncology (01.06.2014)
Get full text
Journal Article
652O Dose-dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as perioperative chemotherapy for patients with muscle-invasive bladder cancer (MIBC): Results of the GETUG/AFU VESPER V05 phase III trial
Pfister, C., Gravis, G., Flechon, A., Chevreau, C.M., Mahammedi, H., Laguerre, B., Guillot, A., Joly, F., Soulie, M., Allory, Y., Harter, V., Culine, S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1977P Efficacy of talazoparib and avelumab as a maintenance treatment in patients with advanced/metastatic urothelial carcinoma (mUC) whose disease did not progress after a first-line platinum-based chemotherapy (PBCT): The GETUG-TALASUR trial
Coquan, E., Boughalem, E., Pouessel, D., Lequesne, J., Calcagno, F., Grellard, J-M., Christy, F., Mahammedi, H., Ladoire, S., Borchiellini, D., Leman, R., Bazille, C., Fontugne, J., Crouzet, L., Flechon, A., Serrate, C., Gravis, G., Clarisse, B., Thiery Vuillemin, A., Joly Lobbedez, F.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
LBA13 Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)
Sartor, O., Castellano Gauna, D.E., Herrmann, K., de Bono, J.S., Shore, N.D., Chi, K.N.N., Crosby, M., Piulats Rodriguez, J.M., Flechon, A., Wei, X.X., Mahammedi, H., Roubaud, G., ova, H., Ghebremariam, S., Kpamegan, E., Kreisl, T.N., Delgoshaie, N., Lehnhoff, K., Morris, M.J., Fizazi, K.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
603P Objective computerized cognitive assessment in men with metastatic castrate-resistant prostate cancer (mCRPC) randomly receiving darolutamide or enzalutamide in the ODENZA trial
Colomba, E., Jonas, S.F., Eymard, J-C., Delva, R., Brachet, P.E., Neuzillet, Y., Penel, N., Roubaud, G., Bompas, E., Mahammedi, H., Longo, R., Helissey, C., Barthelemy, P., Borchiellini, D., Hasbini, A., Priou, F., Saldana, C., Voog, E., Foulon, S., Fizazi, K.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Hormone treatment–related adverse events (HTR AEs) with darolutamide (DARO) in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC) from the phase 3 ARAMIS study
Fizazi, K., Shore, N., Smith, M., Carles, J., Lebret, T., Lietuvietis, V., Mahammedi, H., Rannikko, A., Vjaters, E., Werbrouck, P., Miskic, M., Kuss, I., Le Berre, M., Borghesi, G., Sarapohja, T., Fayerabend, S.
Published in European urology (01.06.2021)
Published in European urology (01.06.2021)
Get full text
Journal Article
712P Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial
Courcier, J., Dalban, C., Laguerre, B., Ladoire, S., Barthélémy, P., Oudard, S., Joly, F., Gravis Mescam, G., Chevreau, C.M., Geoffrois, L., Deluche, E., Rolland, F., Topart, D., Culine, S., Négrier, S., Mahammedi, H., Tantot, F., Escudier, B., Flippot, R., Albiges, L.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA
Colomba, Emeline, Jonas, Sarah Flora, Eymard, Jean-Christophe, Delva, Rémi, Brachet, Pierre Emmanuel, Neuzillet, Yann, Penel, Nicolas, Roubaud, Guilhem, Bompas, Emmanuelle, Mahammedi, Hakim, Longo, Raffaelle, Helissey, Carole, Barthélemy, Philippe, Borchiellini, Delphine, Hasbini, Ali, Priou, Franck, Saldana, Carolina, Voog, Eric, Narcisso, Bérangère, Ladoire, Sylvain, Berdah, Jean-François, Aisenfarb, Jean-Baptiste, Foulon, Stéphanie, Fizazi, Karim
Published in European urology (01.03.2024)
Published in European urology (01.03.2024)
Get full text
Journal Article
715P Nivolumab in pretreated metastatic penile squamous cell carcinoma: Results of the penile cohort from the French AcSé prospective program
Pouessel, D., Beylot-Barry, M., Esma, S.B., De Pontville, M., Coquan, E., Mahammedi, H., Gavoille, C., Ghiringhelli, F., Dereure, O., Spano, J-P., Tosi, D., Fléchon, A., Pannier, D., Augereau, P., Gambotti, L., Legrand, F., Simon, C., Lamrani-Ghaouti, A., Chevret, S., Marabelle, A.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
579MO CheckMate 9KD cohort A2 final analysis: Nivolumab (NIVO) + rucaparib for chemotherapy (CT)-naïve metastatic castration-resistant prostate cancer (mCRPC)
Petrylak, D.P., Perez-Gracia, J.L., Lacombe, L., Bastos, D.A., Mahammedi, H., Kwan, E.M., Zschäbitz, S., Armstrong, A.J., Pachynski, R.K., Goh, J.C., Burotto, M., Gravis, G., McCune, S.L., Vázquez Limón, J.C., Retz, M., Saad, F., Amin, N.P., Li, J., Unsal-Kacmaz, K., Fizazi, K.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Intérêt de la TEP dans le bilan d’extension et l’évaluation de la maladie résiduelle des séminomes testiculaires : étude rétrospective
Bertrand, S., Gauthé, M., Mahammedi, H., Culot, D., Merlin, C., Kelly, A., Veyre, A., Bay, J.-O., Guy, L., Miot-Noirault, E., Mestas, D., Cachin, F.
Published in Médecine nucléaire : imagerie fonctionelle et métabolique (01.05.2012)
Published in Médecine nucléaire : imagerie fonctionelle et métabolique (01.05.2012)
Get full text
Journal Article
A “missed” cryoglobulin: the importance of in vitro calcium concentration
ANDRÉ, MARC, MAHAMMEDI, HAKIM, AUMAITRE, OLIVIER, TRIDON, ARLETTE, TISSOT, JEAN-DANIEL, PIETTE, JEAN-CHARLES
Published in Annals of the rheumatic diseases (01.06.2000)
Published in Annals of the rheumatic diseases (01.06.2000)
Get full text
Journal Article
868PDBrain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial
Flippot, R, Dalban, C, Laguerre, B, Borchiellini, D, Gravis, G, Negrier, S, Chevreau, C M, Joly, F, Geoffrois, L, Ladoire, S, Mahammedi, H, Tantot, F, Escudier, B, Albiges, L
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article